WuXi Biologics (Cayman) Inc (WXXWY)
3.60
-0.13
(-3.49%)
USD |
OTCM |
May 17, 15:57
WuXi Biologics Accounts Payable (Quarterly): 117.55M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 117.55M |
June 30, 2023 | 79.02M |
June 30, 2023 | 79.02M |
December 31, 2022 | 115.14M |
June 30, 2022 | 148.52M |
June 30, 2022 | 148.52M |
December 31, 2021 | 96.92M |
June 30, 2021 | 82.69M |
June 30, 2021 | 82.69M |
December 31, 2020 | 98.88M |
June 30, 2020 | 247.42M |
Date | Value |
---|---|
June 30, 2020 | 247.42M |
December 31, 2019 | 26.56M |
June 30, 2019 | 36.40M |
June 30, 2019 | 36.40M |
December 31, 2018 | 32.12M |
June 30, 2018 | 21.46M |
June 30, 2018 | 21.46M |
December 31, 2017 | 21.03M |
June 30, 2017 | 12.60M |
June 30, 2017 | 12.60M |
December 31, 2016 | 15.12M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
26.56M
Minimum
Dec 2019
247.42M
Maximum
Jun 2020
109.54M
Average
96.92M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
Wuxi AppTec Co Ltd | 238.71M |
Sinovac Biotech Ltd | 17.29M |
CASI Pharmaceuticals Inc | 4.438M |
Zai Lab Ltd | 88.12M |
Gracell Biotechnologies Inc (DELISTED) | -- |